Diana Langworthy: New Episode – Solving the DOAC vs. Warfarin Mystery in Cirrhosis
Diana Langworthy, Associate Professor at University of Minnesota College of Pharmacy, shared a post on LinkedIn:
“New episode going live tomorrow, Tuesday June 30th, on What’s It Worth?
S4E7 – The Cirrhosis Paradox: Solving the DOAC vs. Warfarin Mystery in Liver Disease
Join me and my co-hosts, Dr. Erin E Pauling, (ambulatory care and cardiology specialist from Binghamton University) and recent U of MN grad, Dr. Caleb Nelson-Lange.
In this episode, we dig into a systematic review and meta-analysis comparing DOACs vs. warfarin in patients with atrial fibrillation and liver disease, including cirrhosis.
We talk through:
Why anticoagulation decisions in liver disease are so nuanced
What the evidence suggests about DOAC safety and effectiveness
How to think about agent selection, especially apixaban vs. rivaroxaban
Why observational data can be helpful, but still leaves important clinical gaps
And with this episode, there is a patient-facing companion episode:
S4E7.5 – AFib, Blood Thinners, and Liver Disease: Questions to Ask Your Doctor
This short What’s It Worth? For Everyone episode is designed for patients and families navigating AFib, blood thinners, liver disease, and cirrhosis.
It explains the topic in plain language and ends with practical questions patients can bring to their healthcare team.
For healthcare professionals: listen to the full episode for the evidence deep dive, and consider sharing the companion episode with patients or caregivers who want a clearer starting point for the conversation.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH